These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 37056563)

  • 1. Nanoparticle formulations for therapeutic delivery, pathogen imaging and theranostic applications in bacterial infections.
    Jiang L; Ding L; Liu G
    Theranostics; 2023; 13(5):1545-1570. PubMed ID: 37056563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ruthenium complexes/polypeptide self-assembled nanoparticles for identification of bacterial infection and targeted antibacterial research.
    Huang N; Chen X; Zhu X; Xu M; Liu J
    Biomaterials; 2017 Oct; 141():296-313. PubMed ID: 28709020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Voyage of theranostic liposomes for imaging and therapy.
    Sachin M; Sachin D; Dinesh S
    J Cosmet Laser Ther; 2017 Aug; 19(4):245-249. PubMed ID: 28135901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in cell membrane camouflaged nanotherapeutics for the treatment of bacterial infection.
    Jia Y; Zhang L; Xu J; Xiang L
    Biomed Mater; 2024 May; 19(4):. PubMed ID: 38697197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards tailored management of malignant brain tumors with nanotheranostics.
    Aparicio-Blanco J; Torres-Suárez AI
    Acta Biomater; 2018 Jun; 73():52-63. PubMed ID: 29678675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the applications of hyaluronic acid-based nanoparticles for diagnosis and treatment of bacterial infections.
    Mohammed M; Devnarain N; Elhassan E; Govender T
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Jul; 14(4):e1799. PubMed ID: 35485247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanomedicine for the Detection and Treatment of Ocular Bacterial Infections.
    Huang X; Li L; Chen Z; Yu H; You X; Kong N; Tao W; Zhou X; Huang J
    Adv Mater; 2023 Nov; 35(46):e2302431. PubMed ID: 37231939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nano-therapeutics: A revolution in infection control in post antibiotic era.
    Zaidi S; Misba L; Khan AU
    Nanomedicine; 2017 Oct; 13(7):2281-2301. PubMed ID: 28673854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticle approaches against bacterial infections.
    Gao W; Thamphiwatana S; Angsantikul P; Zhang L
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2014; 6(6):532-47. PubMed ID: 25044325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging trends in aggregation induced emissive luminogens as bacterial theranostics.
    Kumari R; Sunil D
    J Drug Target; 2021 Sep; 29(8):793-807. PubMed ID: 33583291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Green Synthesized Nanomaterials as Theranostic Platforms for Cancer Treatment: Principles, Challenges and the Road Ahead.
    Rajasekharreddy P; Huang C; Busi S; Rajkumari J; Tai MH; Liu G
    Curr Med Chem; 2019; 26(8):1311-1327. PubMed ID: 28294042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are nanotheranostics and nanodiagnostics-guided drug delivery stepping stones towards precision medicine?
    Blau R; Krivitsky A; Epshtein Y; Satchi-Fainaro R
    Drug Resist Updat; 2016 Jul; 27():39-58. PubMed ID: 27449597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicological considerations when creating nanoparticle-based drugs and drug delivery systems.
    Sharma A; Madhunapantula SV; Robertson GP
    Expert Opin Drug Metab Toxicol; 2012 Jan; 8(1):47-69. PubMed ID: 22097965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Advances in Oral Nano-Antibiotics for Bacterial Infection Therapy.
    Wu ZL; Zhao J; Xu R
    Int J Nanomedicine; 2020; 15():9587-9610. PubMed ID: 33293809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomedical applications of 2D monoelemental materials formed by group VA and VIA: a concise review.
    Gao P; Xiao Y; YuliangWang ; Li L; Li W; Tao W
    J Nanobiotechnology; 2021 Apr; 19(1):96. PubMed ID: 33794908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand Chemistry in Antitumor Theranostic Nanoparticles.
    Lin G; Zhang M
    Acc Chem Res; 2023 Jun; 56(12):1578-1590. PubMed ID: 37220248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor-Targeted Surface-Engineered Nanomaterials for Breast Cancer Imaging and Theranostic Applications.
    Ahmad J; Rizwanullah M; Suthar T; Albarqi HA; Ahmad MZ; Vuddanda PR; Khan MA; Jain K
    Crit Rev Ther Drug Carrier Syst; 2022; 39(6):1-44. PubMed ID: 35997100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineered Hybrid Nanoparticles for On-Demand Diagnostics and Therapeutics.
    Nguyen KT; Zhao Y
    Acc Chem Res; 2015 Dec; 48(12):3016-25. PubMed ID: 26605438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacteria-Activated Theranostic Nanoprobes against Methicillin-Resistant Staphylococcus aureus Infection.
    Zhao Z; Yan R; Yi X; Li J; Rao J; Guo Z; Yang Y; Li W; Li YQ; Chen C
    ACS Nano; 2017 May; 11(5):4428-4438. PubMed ID: 28350437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Nanoantibiotics": a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era.
    Huh AJ; Kwon YJ
    J Control Release; 2011 Dec; 156(2):128-45. PubMed ID: 21763369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.